New Releases from NCBI BookshelfBRAF and MEK Inhibitors for Active or Symptomatic Melanoma Brain Metastasis: Health Technologies [Internet].​BRAF and MEK Inhibitors for Active or Symptomatic Melanoma Brain Metastasis: Health Technologies [Internet].

By /

This rapid review examines the clinical efficacy, effectiveness, and safety of BRAF and MEK inhibitors as a treatment for patients with active or symptomatic melanoma brain metastasis (MBM).

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top